| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/27/2003 | US20030219791 Transducer of MAS signalling |
| 11/27/2003 | US20030219789 36P6D5: secreted tumor antigen |
| 11/27/2003 | US20030219787 Comprises nucleotide sequences for detecting and analyzing restriction fragment length polymorphhisms associated with information processing brain disorders |
| 11/27/2003 | US20030219786 Novel glycoproteins and methods of use thereof |
| 11/27/2003 | US20030219777 Comprises expression vector coding sequences for detecting gene position of atherosclerosis susceptibility gene and for modulating cholesterol phenotypes in cells |
| 11/27/2003 | US20030219774 Comprises nucleotide sequences coding g-protein coupled receptors for treating pain, nervous system, psychological, circadian rhythm, hypotensive, hypertensive and eating disorders |
| 11/27/2003 | US20030219761 Novel prostate-specific or test-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/27/2003 | US20030219758 Comprises nucleotide sequences for diagnosis, prevention and treatment of metastasis, autoimmune and nervous system disorders |
| 11/27/2003 | US20030219750 Schizophrenia associated genes, proteins and biallelic markers |
| 11/27/2003 | US20030219748 Regulated prostate cancer genes |
| 11/27/2003 | US20030219747 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 11/27/2003 | US20030219745 Novel nucleic acids and polypeptides |
| 11/27/2003 | US20030219744 Comprises nucleotide sequences for detecting protein factors; forensics; genetic mapping; evaluating biodiversity |
| 11/27/2003 | US20030219743 Comprises nucleotide sequences for detecting protein factors; forensics; genetic mapping; evaluating biodiversity |
| 11/27/2003 | US20030219741 Novel full-length cDNA |
| 11/27/2003 | US20030219740 DNA sequences isolated from human colonic epithelial cells |
| 11/27/2003 | US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy |
| 11/27/2003 | US20030219738 Nucleic acid and encoded zinc transporter protein entitled 108P5H8 useful in treatment and detection of cancer |
| 11/27/2003 | US20030219732 Adaptation sites of porcine reproductive and respiratory syndrome virus |
| 11/27/2003 | US20030219728 Comprises nucleotide sequences coding HIV-associated life preserver (HALP) protein for treating apoptosis disorders; viricides; antiapoptosis; genetic vaccines |
| 11/27/2003 | US20030219724 Identifying signal sequences which facilitate the transfer of active agents through human and animal tissues; drug delivery |
| 11/27/2003 | US20030219722 Comprises preparation of novel binding prolypeptides via mutagenesis, expression, chromatographic selection and amplification; drug screening |
| 11/27/2003 | US20030219721 Dissecting the regulatory circuitry of a eukaryotic genome |
| 11/27/2003 | US20030219717 Modified green fluorescent protein peptides for use as diagnostic tool in measuring protein-protein interaction; drug screening |
| 11/27/2003 | US20030219486 Crosslinking agent reacts with reactive pendant groups existing on the keratin molecules to produce biocompatible heterogenous proteinaceous networks crosslinked with the heterogenous crosslinker |
| 11/27/2003 | US20030219462 Clostridial neurotoxin compositions and modified clostridial neurotoxins |
| 11/27/2003 | US20030219459 Fusion proteins; epitopes; microarrays; vaccines |
| 11/27/2003 | US20030219458 Multivalent vaccination using recombinant adenovirus |
| 11/27/2003 | US20030219457 Derived from Clostridium proteins; immunogens; fusion proteins; vaccines |
| 11/27/2003 | US20030219455 Antigens, polynucleotides; kits |
| 11/27/2003 | US20030219454 Isolated from Haemophilus paragallinarum; for vaccinating chickens against infectious coryza |
| 11/27/2003 | US20030219452 HIV envelope V3-CCR5 binding site immunogen |
| 11/27/2003 | US20030219451 Stable helical C peptides and uses therefor |
| 11/27/2003 | US20030219450 Tat/rev/vpr/nef genes/proteins for vaccines |
| 11/27/2003 | US20030219449 Glycoproteins for screening animals; vaccines; gene therapy kits |
| 11/27/2003 | US20030219448 Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases |
| 11/27/2003 | US20030219446 Ligand for CD28 receptor on B cells and methods |
| 11/27/2003 | US20030219444 Genes and encoded polypeptides expressed in cancer cells, used for diagnosis, prophylaxis and as targets of tumors; vaccines |
| 11/27/2003 | US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders |
| 11/27/2003 | US20030219436 Immobilized and soluble forms of CD antigens used for immunology modulation, prophylaxis of inflammation, autoimmune diseases, graft versus host disease and cancer |
| 11/27/2003 | US20030219427 Modulation of nuclear factor kappa beta activity using tumor progression locus (TPL-2) molecules; phosphorylation of proteins; controlling immune and inflammatory responses |
| 11/27/2003 | US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives |
| 11/27/2003 | US20030219424 Polynucleotide codes for amino acid sequences used for medical diagnosis, prophylaxis autoimmune diseases, as antiallergens or antitumor agents |
| 11/27/2003 | US20030219423 Methods of inducing or enhancing connective tissue repair |
| 11/27/2003 | US20030219421 Genetic vectors comprising polynucleotide codes for vitamin D-dependent calcium binding protein, administered for prevention of apoptosis in cells and prophylaxis of osteoporosis |
| 11/27/2003 | US20030219419 Alteration of cell membrane for new functions |
| 11/27/2003 | US20030219415 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 11/27/2003 | US20030219413 Method for overexpression of zwitterionic polysaccharides |
| 11/27/2003 | US20030219412 Somatic gene therapy to suppress secondary cataract formation following eye surgery |
| 11/27/2003 | US20030219411 Modulators of the function of FAS receptors and other proteins |
| 11/27/2003 | US20030219407 A genetic engineered DNA for treating or preventing a viral infections |
| 11/27/2003 | US20030219403 Compositions and methods of tolerizing a primate to an antigen |
| 11/27/2003 | US20030219402 Drug delivery of a fusion protein comprising plurality of component molecules linked with a linker, containing an enzyme cleavage site to be cleaved by an enzyme in a treated subject |
| 11/27/2003 | US20030219382 Cancer-linked gene as target for chemotherapy |
| 11/27/2003 | US20030219378 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 11/27/2003 | US20030219376 Progression elevated Gene-3 and uses thereof |
| 11/27/2003 | US20030219375 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 11/27/2003 | CA2830619A1 Glucan-based vaccines |
| 11/27/2003 | CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 11/27/2003 | CA2524892A1 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof |
| 11/27/2003 | CA2494359A1 Bcg vaccine and utilization thereof |
| 11/27/2003 | CA2493820A1 Promoter sequences for urocortin ii the use thereof |
| 11/27/2003 | CA2487642A1 Collagen and method for producing same |
| 11/27/2003 | CA2486913A1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector |
| 11/27/2003 | CA2486603A1 Card-4 molecules and uses thereof |
| 11/27/2003 | CA2486583A1 Marker molecules associated with lung tumors |
| 11/27/2003 | CA2486576A1 Sodium channel regulators and modulators |
| 11/27/2003 | CA2486483A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 11/27/2003 | CA2486450A1 Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles |
| 11/27/2003 | CA2486327A1 Htlv-i tax induced killing of p53 null cancer cells |
| 11/27/2003 | CA2486112A1 Allergen mutants |
| 11/27/2003 | CA2486060A1 Cancer-linked gene as target for chemotherapy |
| 11/27/2003 | CA2485983A1 Cancer-linked gene as target for chemotherapy |
| 11/27/2003 | CA2485981A1 Cancer-linked gene as target for chemotherapy |
| 11/27/2003 | CA2485847A1 Glucan-based vaccines |
| 11/27/2003 | CA2485453A1 Polypeptide antigen inducing hiv neutralizing antibodies |
| 11/27/2003 | CA2484955A1 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum |
| 11/27/2003 | CA2484719A1 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 11/27/2003 | CA2484295A1 Attenuation of metapneumovirus |
| 11/27/2003 | CA2483712A1 Use of modified novirhabdoviruses to obtain vaccines |
| 11/27/2003 | CA2483692A1 Constitutively translocating cell line |
| 11/27/2003 | CA2483640A1 Fusion protein of hiv regulatory/accessory proteins |
| 11/27/2003 | CA2483616A1 Method, use and kit for separating albumin from contaminants in a liquid |
| 11/27/2003 | CA2483612A1 Method for albumin purification |
| 11/27/2003 | CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 11/27/2003 | CA2390972A1 Bovine viral diarrhea virus (bvdv) p80 and p80.delta.50 proteins as inducers of cell apoptosis |
| 11/27/2003 | CA2383607A1 Bovine viral diarrhea virus (bvdv) p80 and p80.delta.50 proteins as inducers of cell apoptosis in vitro |
| 11/26/2003 | EP1365032A1 Marker molecules associated with lung tumors |
| 11/26/2003 | EP1365030A1 G-protein coupled receptor marker molecules associated with colorectal lesions |
| 11/26/2003 | EP1365028A1 Method for expression of PDGF or IGF proteins in yeast |
| 11/26/2003 | EP1365027A2 Fas ligand-fused proteins |
| 11/26/2003 | EP1365024A1 Traf3-binding b cell-specific receptor |
| 11/26/2003 | EP1365022A1 Adiponectin-associated protein |
| 11/26/2003 | EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies |
| 11/26/2003 | EP1364968A1 Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (AVPR1) |
| 11/26/2003 | EP1364967A2 Glucagon-like insulinotropic peptides, compositions and methods |
| 11/26/2003 | EP1364966A2 Production of recombinant human epidermal growth factor in plants |
| 11/26/2003 | EP1364965A1 Slit1 and MEGF4 isoforms and uses thereof |
| 11/26/2003 | EP1364964A1 Radiolabeled annexingalactose conjugates |
| 11/26/2003 | EP1364963A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |